Release Date: October 4, 2010
National Institute on Drug Abuse (NIDA)
The National Institute on Drug Abuse is issuing this Notice to clarify that applicants for the NIDA Avant-Garde Award for HIV/AIDS should note that the X02 pre-application (PAR-10-287 (X02)) requires (NIH policy) the inclusion of a one page Specific Aims.
However, the one page Specific Aims should not be included in the DP1 Application (RFA-DA-11-002 (DP1)). The 5 page Essay section should be essentially the same in both the X02 and DP1 submissions, therefore, X02 applicants are strongly urged to avoid making reference to the Specific Aims in the Essay.
Please direct all inquiries to:
Jacques Normand, Ph.D.
Director, AIDS Research Program
National Institute on Drug Abuse
National Institutes of Health
6001 Executive Blvd
Rm 5274 MSC 9581
Bethesda, MD 20892
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
Office of Extramural
National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
Department of Health
and Human Services (HHS)